CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Orexigen Therapeutics, Inc.  (OREX)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 

OREX's Revenue Year on Year Growth by Quarter and Year

Orexigen Therapeutics,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
OREX Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 13.88 4.93 22.95
III Quarter September - 7.00 9.97 30.86
II Quarter June - 7.79 5.19 0.86
I Quarter March 19.15 5.03 4.36 0.86
FY   19.15 33.70 24.45 55.53

Financial Statements
Orexigen Therapeutics,'s first quarter 2017 Revenue $ 19.15 millions OREX's Income Statement
Orexigen Therapeutics,'s first quarter 2016 Revenue $ 5.03 millions Quarterly OREX's Income Statement
OREX's Growth by Division See OREX's Growth by Segment

OREX Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 181.54 % -78.52 % 2568.6 %
III Quarter September - -29.79 % -67.69 % 3488.37 %
II Quarter June - 50.1 % 503.49 % 0 %
I Quarter March 280.62 % 15.37 % 406.98 % 0 %
FY   - 37.83 % -55.97 % -



OREX Revenue Growth Comment
Orexigen Therapeutics, Inc. reported Revenue surge of 280.62% year on year in the first quarter, to $ 19.15 millions, this is lower than Orexigen Therapeutics, Inc.'s recent average Revenue surge of 432.03%.

Looking into first quarter results within Major Pharmaceutical Preparations industry 10 other companies have achieved higher Revenue growth. While Orexigen Therapeutics, Inc.' s Revenue doubling of 280.62% ranks overall at the positon no. 108 in the first quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #11
Healthcare Sector #27
Overall #108
Revenue Y/Y Growth Statistics
High Average Low
3500.58 % 432.03 % -78.51 %
(Sep 30 2014)   (Dec 31 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OREX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for OREX's Competitors
Revenue Growth for Orexigen Therapeutics,'s Suppliers
Revenue Growth for OREX's Customers

You may also want to know
OREX's Annual Growth Rates OREX's Profitability Ratios OREX's Asset Turnover Ratio OREX's Dividend Growth
OREX's Roe OREX's Valuation Ratios OREX's Financial Strength Ratios OREX's Dividend Payout Ratio
OREX's Roa OREX's Inventory Turnover Ratio OREX's Growth Rates OREX's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Cytomx Therapeutics, Inc.  424.20 %$ 424.202 millions
Sientra, Inc.  409.11 %$ 409.109 millions
Sorrento Therapeutics, Inc.  393.32 %$ 393.320 millions
Bluebird Bio, Inc.  355.77 %$ 355.771 millions
Agenus Inc  352.36 %$ 352.365 millions
Protalix Biotherapeutics, Inc.  325.48 %$ 325.479 millions
Lifestyle Medical Network, Inc.  319.44 %$ 319.438 millions
Orexigen Therapeutics, Inc.  280.39 %$ 280.389 millions
Intellia Therapeutics, Inc.  249.75 %$ 249.747 millions
Biolargo, Inc.  230.06 %$ 230.060 millions
Corbus Pharmaceuticals Holdings, Inc.  226.20 %$ 226.199 millions
Exact Sciences Corp  226.01 %$ 226.006 millions
Accelerate Diagnostics, Inc.  225.15 %$ 225.153 millions
American Cryostem Corp  205.95 %$ 205.946 millions
Ionis Pharmaceuticals Inc  199.14 %$ 199.138 millions
Immune Design Corp.  193.34 %$ 193.344 millions
Transgenomic Inc  178.81 %$ 178.814 millions
Icu Medical Inc  175.71 %$ 175.710 millions
Novocure Ltd  167.22 %$ 167.218 millions
Invitae Corp  161.39 %$ 161.391 millions
Eagle Pharmaceuticals, Inc.  159.51 %$ 159.515 millions
Alnylam Pharmaceuticals, Inc.  158.13 %$ 158.135 millions
Catasys, Inc.  150.27 %$ 150.275 millions
Catalyst Biosciences, Inc.  148.62 %$ 148.624 millions